StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)

Close on Nov 17, 2026Market cap $41.33MP/E –Yield –

Harvard Bioscience EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Harvard Bioscience's EV/EBITDA was 104.7× on Apr 30, 2024, against 88.8× a year earlier. Over the last 5 years it ranged from 27.2× to 963.6×, with a median of 104.9×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 2024104.7×−122.2
2023Dec 29, 2023226.9×+103.2
2022Apr 29, 2022123.7×+18.8
2021Dec 31, 2021104.9×−284.5
2020Apr 30, 2020389.4×+57.5
2019Dec 31, 2019331.9×−40.6
2016Jan 29, 2016372.5×−57.5
2015Dec 31, 2015430.0×+380.7
2014Dec 31, 201449.3×+30.8
2013Dec 31, 201318.6×+8.8
2012Dec 31, 20129.7×−1.6
2011Dec 30, 201111.3×−1.8
2010Dec 31, 201013.1×–

More Harvard Bioscience figures

See a number that looks wrong?